ABEONA THERAPEUTICS INC - COM (ABEO)

CUSIP: 00289Y107

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM
Total 13F shares
19,617,144
Share change
+4,097,213
Total reported value
$334,470,272
Put/Call ratio
16%
Price per share
$17.05
Number of holders
73
Value change
+$83,896,681
Number of buys
40
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 00289Y107?
CUSIP 00289Y107 identifies ABEO - ABEONA THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ABEONA THERAPEUTICS INC - COM (ABEO) as of Q3 2017

As of 30 Sep 2017, ABEONA THERAPEUTICS INC - COM (ABEO) was held by 73 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,617,144 shares. The largest 10 holders included Knoll Capital Management, LP, Viking Global Investors LP, ADAGE CAPITAL PARTNERS GP, L.L.C., BAKER BROS. ADVISORS LP, BlackRock Inc., CITADEL ADVISORS LLC, Castle Hook Partners LP, VANGUARD GROUP INC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, and Cormorant Asset Management, LLC. This page lists 73 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.